Smoking cessation 3: Nicotinic partial agonists in smoking cessation - Varenicline and cytisine
Cigarette smoking is the most preventable cause of illness, death, and excess healthcare costs in the UK. Most smokers want to stop smoking and intend to stop at some point. In this third article in our series on smoking cessation in primary care, we look at the evidence for the use of nicotinic par...
Главные авторы: | Aveyard, P, Parsons, A, Begh, R |
---|---|
Формат: | Journal article |
Язык: | English |
Опубликовано: |
2009
|
Схожие документы
-
An integrated approach to pharmacotherapy in smoking cessation: the role of varenicline, bupropion, cytisine, and nicotine replacement therapy
по: Kacper Więcław, и др.
Опубликовано: (2023-08-01) -
The place of varenicline in smoking cessation treatment.
по: Aveyard, P
Опубликовано: (2008) -
Smoking cessation 4: Antidepressants for smoking cessation - Bupropion and nortriptyline
по: Aveyard, P, и др.
Опубликовано: (2010) -
Placebo-controlled trial of cytisine for smoking cessation.
по: West, R, и др.
Опубликовано: (2011) -
Nicotine receptor partial agonists for smoking cessation
по: Livingstone-Banks, J, и др.
Опубликовано: (2023)